Top Markets
#1 MowCat MowCat +48.89%
#2 Bermuda Shorts Bermuda Shorts +30.33%
#3 Velvet Velvet +26.11%
#4 Biconomy Biconomy +24.38%
#5 aPriori aPriori +22.89%
#6 Derive Derive +19.95%
#7 Audiera Audiera +18.63%
#8 Quack AI Quack AI +16.83%
#9 Perle Perle +13.71%
#10 Block Street Block Street +10.44%
Coin of the day
MowCat MowCat
設定
言語
日本
通貨
USD
テーマ
Mustang Bio, Inc. Mustang Bio, Inc.

Mustang Bio, Inc.

MBIO
株式のランク #35075
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on... Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-109, a combination MB-101 and MB-108 as a potential treatment for IL13Ra2+ relapsed or refractory glioblastoma and high-grade astrocytoma; MB-101, an IL13Ra2 CAR T cell program completd Phase I for glioblastoma; and MB-108 which is in Phase I for the treatment of herpes simplex virus-1 oncolytic virus C134. It has a license agreement with city of hope national medical center and nationwide children’s hospital. Mustang Bio, Inc. was incorporated in 2015 and is headquartered in Waltham, Massachusetts.
株価
$0.594
最終同期: 2026-08-14
時価総額
$4.50M
変化（1日）
0.00%
変化（1年）
-66.44%
国
US
取引 Mustang Bio, Inc. (MBIO)

カテゴリー

Healthcare
Mustang Bio, Inc.（MBIO）の株式分割履歴
Mustang Bio, Inc.株（シンボル：MBIO）は合計で0回の株式分割を実施しました。
最新の株式分割はAug 16, 2026に行われました。
Aug 16, 2026より前に購入されたMBIO株は、現在0MBIO株に相当します。
株式分割一覧
年 株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE